Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Long QT Syndrome

Genetics in Medicine- United States

doi 10.1097/gim.0b013e3181d68293

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Impact of Gene Patents and Licensing Practices on Access to Genetic Testing for Alzheimer Disease

Genetics in Medicine
MedicineGenetics
2010English

Impact of Gene Patents and Licensing Practices on Access to Genetic Testing and Carrier Screening for Tay-Sachs and Canavan Disease

Genetics in Medicine
MedicineGenetics
2010English

Comment on the Impact of Gene Patents and Licensing Practices on Access to Genetic Testing: Lessons From Hereditary Hemorrhagic Telangiectasia

Genetics in Medicine
MedicineGenetics
2010English

Non Genetic Risk Factors of Long-Qt Syndrome

Open Journal of Genetics
2012English

How to Perform and Interpret Provocative Testing for the Diagnosis of Brugada Syndrome, Long-Qt Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2011English

Familial Long QT Syndrome

2020English

Congenital Long QT Syndrome

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2008English

Parmacogenomics of Long QT Syndrome

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2004English

Zebrafish Model for Human Long QT Syndrome

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007Spanish

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy